2024-04-15 11:55:18 ET
Summary
- Intuitive Surgical is set to report Q1 earnings later this week, and the company has previously outperformed with substantial revenue and EPS beats.
- The company leads in robotic surgery with high service revenue and margins; da Vinci 5 launch is anticipated next year.
- Financially robust, Intuitive Surgical shows strong cash reserves and operating cash flow, maintaining a healthy balance sheet.
- Investment Recommendation: Maintain a "Buy" on ISRG, leveraging its market dominance and ongoing innovation, despite valuation risks.
Intuitive Surgical Q1 Earnings and Strategic Outlook
Intuitive Surgical, Inc. ( ISRG ) reports Q1 earnings this Thursday. Last earnings saw a healthy beat on EPS ($1.60, beat by $0.11) and revenue ($1.93 billion, beat by $30.14 million). In December, I applauded the firm's 700% stock return in the past decade and expressed optimism over their cutting-edge growth in robotic surgery. Despite a high valuation at that time (P/E ratio of 60), I recommended a Buy on ISRG stock. Since then, ISRG has returned 14.21%, nearly twice the 7.66% gained by the S&P 500 ( SP500 )....
Read the full article on Seeking Alpha
For further details see:
Intuitive Surgical Readies For Robotic Resurgence In Upcoming Earnings